Que reste-t-il de l’héparine à la phase aiguë de l’ischémie cérébrale ?
作者： E. Touzé , C. Arquizan , J.-L. Mas
DOI: 10.1016/S0035-3787(04)71027-9
关键词:
摘要:
sci-hub.se 参考文章(49)
International Stroke Trial Collaborative Group, None, The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke The Lancet. ,vol. 349, pp. 1569- 1581 ,(1997)
Marie-Germaine Bousser, Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke. ,vol. 30, pp. 481- 483 ,(1999) , 10.1161/01.STR.30.3.481
Philip M. W. Bath, Robert Iddenden, Fiona J. Bath, Low-Molecular-Weight Heparins and Heparinoids in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials Stroke. ,vol. 31, pp. 1770- 1778 ,(2000) , 10.1161/01.STR.31.7.1770
Hans Christoph Diener, Erich Bernd Ringelstein, Rüdiger von Kummer, Hans Dieter Langohr, Heiko Bewermeyer, Helmut Landgraf, Michael Hennerici, Dieter Welzel, Michael Gräve, Joachim Brom, Gottfried Weidinger, Treatment of Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin Results of the TOPAS Trial Stroke. ,vol. 32, pp. 22- 29 ,(2001) , 10.1161/01.STR.32.1.22
S.T. Engelter, P.A. Lyrer, E.C. Kirsch, A.J. Steck, Long-Term Follow-Up after Extracranial Internal Carotid Artery Dissection European Neurology. ,vol. 44, pp. 199- 204 ,(2000) , 10.1159/000008236
Beat J. Meyer, Antithrombotic Drugs:Insights f rom Cardiology Cerebrovascular Diseases. ,vol. 8, pp. 19- 27 ,(1998) , 10.1159/000047514
Joan T. Moroney, Emilia Bagiella, Myunghee C. Paik, Ralph L. Sacco, David W. Desmond, Risk Factors for Early Recurrence After Ischemic Stroke The Role of Stroke Syndrome and Subtype Stroke. ,vol. 29, pp. 2118- 2124 ,(1998) , 10.1161/01.STR.29.10.2118
Majaz Moonis, Marc Fisher, Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke Stroke. ,vol. 33, pp. 1927- 1933 ,(2002) , 10.1161/01.STR.0000019422.63054.5F
Jack Hirsh, Theodore E. Warkentin, Stephen G. Shaughnessy, Sonia S. Anand, Jonathan L. Halperin, Robert Raschke, Christopher Granger, E. Magnus Ohman, James E. Dalen, Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Chest. ,vol. 119, pp. 64- ,(2001) , 10.1378/CHEST.119.1_SUPPL.64S
Peter Sandercock, Full Heparin Anticoagulation Should Not Be Used in Acute Ischemic Stroke Stroke. ,vol. 34, pp. 231- 232 ,(2003) , 10.1161/01.STR.0000047037.38062.24